RE: why would anyone want to takeover a company that's had rejections of assets?18 Nov 2022 13:53
I can see what is happening in front of me. If we put aside communication re BoD which I concur on, This is the MM's more than playing on emotions. there is a delay it is non-clinical = testing protocols et al . It is nothing to do with the clinical aspect and compunds - end of. The fact we are here from c1.60 is nothing more than demonstrating a lightly regulated AIM market. As someone said <1% of the share capital transacted this am & 10% down. If that is not bullcarp then tell me what is.